As of Apr 21
| +0.11 / +21.87%|
The 1 analysts offering 12-month price forecasts for CytRx Corp have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +552.53% increase from the last price of 0.61.
The current consensus among 1 polled investment analysts is to Buy stock in CytRx Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.